Infection with multi‑drug resistant organisms in patients with limb fractures: Analysis of risk factors and pathogens

Honggang Sun1, Dagao Dong1, Min Zhao1

  • 1Clinical Laboratory, Bayi Orthopedic Hospital, Chengdu, Sichuan 610052, P.R. China.

Biomedical Reports
|January 23, 2024
PubMed

Insights

Multi-drug resistant organism (MDRO) infections are a growing threat, especially after limb fracture surgery. Key risk factors include being bedridden, prolonged operative time, and repeated infections, highlighting the need for preventative strategies.

Area of Science:

  • Infectious Diseases
  • Orthopedic Surgery
  • Microbiology

Background:

  • Multi-drug resistant organisms (MDROs) pose a significant global health challenge, particularly in healthcare settings.
  • Antibiotic overuse is a primary driver of antimicrobial resistance.
  • Patients with limb fractures undergoing surgery are at increased risk of MDRO infections.

Purpose of the Study:

  • To identify risk factors associated with postoperative multi-drug resistant organism (MDRO) infections in patients with limb fractures.
  • To analyze the relationship between various clinical factors and the incidence of MDRO infections post-surgery.

Main Methods:

  • A retrospective cohort study was conducted using data from January 2020 to August 2022.
  • Involved 114 patients with postoperative surgical site infections, of which 47 had MDRO infections.
  • Utilized univariate and multivariate logistic regression to determine risk factors.

Main Results:

  • Multivariate analysis identified being bedridden (OR, 2.66), repeated infection (OR, 4.00), and operative time exceeding 3 hours (OR, 2.28) as significant risk factors for MDRO infection.
  • Gram-positive bacteria, including Staphylococcus aureus, were prevalent.
  • MDROs like MRSA and ESBL-producing gram-negative bacilli were identified.

Conclusions:

  • Constraining antibiotic use, reducing operative time, and promoting early patient activity are crucial for preventing MDRO surgical-site infections in fracture patients.
  • Targeted interventions focusing on identified risk factors can mitigate MDRO infection rates.